间歇性跛行的血运重建:改变一种良性疾病自然史的做法
本文通过检索PubMed与Google Scholar,比较保守治疗与血运重建治疗间歇性跛行的结局。综述指出,尽管血运重建后跛行症状早期改善,但长期结局常不优于保守治疗,且再干预率、急慢性肢体缺血及截肢风险更高,进而提出早期血运重建前知情同意应告知其对自然史的潜在负面影响。
要点
- 专业学会指南明确血运重建仅用于保守治疗失败的致残性跛行患者。
- 血运重建后长期结局常不优于保守治疗,再干预率可高达43%(胫动脉斑块旋切术)。
- 早期血运重建患者长期随访截肢率可高达11%,且不良心血管事件发生率更高。
核心结论
- 血运重建会对间歇性跛行的自然史产生负面影响,常导致多次干预、急慢性肢体缺血发生率增加及截肢风险升高。
- 作者认为,对接受早期血运重建的患者进行知情同意时,必须告知血运重建对跛行自然史的潜在负面影响。
研究设计与样本
- 综述:检索Google Scholar与PubMed中关于间歇性跛行保守治疗及血运重建后结局的文献。
主要发现
- 血运重建后跛行症状早期改善,但多项研究显示其长期结局常不优于保守治疗。
- 胫动脉斑块旋切术后再干预率高达43%,导致急性和慢性肢体缺血发生率高于接受药物治疗的患者。
- 接受早期血运重建的患者长期随访截肢率高达11%。
- 接受早期血运重建的患者心肌梗死等不良心血管事件发生率高于药物治疗患者。
关键数值与推荐
- 专业学会指南明确:血运重建手术仅应在保守治疗失败的致残性跛行患者中实施。
临床怎么用
- 作者认为,对接受早期血运重建的患者进行知情同意时,必须告知血运重建对跛行自然史的潜在负面影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The benign natural history of intermittent claudication was first documented in 1960 and has been reconfirmed in several subsequent studies. Excellent outcomes in patients with intermittent claudication can be achieved with exercise therapy and optimal medical management. Professional society guidelines have clearly stated that revascularization procedures should be performed only in patients with incapacitating claudication who have failed conservative therapy. Despite these guidelines, revascularization procedures, primarily percutaneous interventions, have been increasingly utilized in patients with claudication. Many of these patients are not even offered an attempt at medical therapy, and those who are often do not undergo a full course of treatment. Many studies document significant reintervention rates following revascularization, which are associated with increased rates of acute and chronic limb ischemia that may result in significant rates of amputation. The objectives of this study were to compare outcomes of conservative therapy to those seen in patients undergoing revascularization procedures and to determine the impact of revascularization on the natural history of claudication. METHODS: Google Scholar and PubMed were searched for manuscripts on the conservative management of claudication and for those reporting outcomes following revascularization for claudication. RESULTS: Despite early improvement in claudication symptoms following revascularization, multiple studies have demonstrated that long-term outcomes following revascularization are often no better than those obtained with conservative therapy. High reintervention rates (up to 43% for tibial atherectomies) result in high rates of both acute and chronic limb ischemia as compared with those patients undergoing medical therapy. In addition, amputation rates as high as 11% on long-term follow-up are seen in patients undergoing early revascularization. These patients also have a higher incidence of adverse cardiovascular events such as myocardial infarctions compared with patients treated medically. CONCLUSIONS: Revascularization procedures negatively impact the natural history of claudication often resulting in multiple interventions, an increase in the incidence of acute and chronic limb ischemia, and an increased risk of amputation. Accordingly, informed consent requires that all patients undergoing early revascularization must be appraised of the potential negative impact of revascularization on the natural history of claudication.
引用
- McCready RA, Brown OW, Kiell CS, et al. Revascularization for claudication: Changing the natural history of a benign disease! J Vasc Surg. 2023. PMID: 37619917. doi:10.1016/j.jvs.2023.07.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。